Rankings
▼
Calendar
MAZE FY 2024 Earnings — Maze Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
MAZE
Maze Therapeutics, Inc.
$2B
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$168M
Gross Profit
$168M
100.0% margin
Operating Income
$58M
34.4% margin
Net Income
$52M
31.2% margin
EPS (Diluted)
$0.08
Cash Flow
Operating Cash Flow
$76M
Free Cash Flow
$75M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$241M
Total Liabilities
$44M
Stockholders' Equity
$197M
Cash & Equivalents
$197M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$168M
$0
—
Gross Profit
$168M
$0
—
Operating Income
$58M
-$99M
+158.4%
Net Income
$52M
-$100M
+152.0%
← Q4 2023
All Quarters
Q1 2024 →